Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Dimension Therapeutics, Inc. (DMTX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-17Jun-30-17Mar-31-17Dec-31-16Sep-30-16Jun-30-16Mar-31-16Dec-31-15
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Revenue  4.54.43.64.12.82.42.22.4
            Revenue growth  62.2%84.3%64.0%75.6%34.0%36.1%38.4%67.2%
Operating expenses:          
Research and development  16.114.113.713.913.811.28.88.8
General and administrative  5.32.63.43.33.33.22.92.6
    Total operating expenses  43.533.717.117.217.114.511.711.4
    Loss from operations  -17.0-12.3-13.5-13.1-14.3-12.1-9.5-9.0
            Operating margin  -378.9%-282.2%-373.9%-316.2%-519.2%-510.5%-432.5%-382.9%
Interest income, net  0.00.00.00.00.00.00.00.0
    Net loss  -16.9-12.3-13.5-13.0-14.4-12.1-9.5-9.0
   
Net loss per share — basic and diluted  ($0.68)($0.49)($0.54)($0.53)($0.58)($0.49)($0.38)$2.30
   
Weighted average common shares outstanding — basic and diluted  25.125.025.024.924.924.924.97.9
   
Comprehensive loss:          
Net loss  -16.9-12.3-13.5-13.0-14.4-12.1-9.5-9.0
   
Other comprehensive loss:          
Unrealized gain (loss) on marketable securities  0.00.0  0.0   
   
    Total other comprehensive gain (loss)          
    Total comprehensive loss  -16.9-12.3-13.5-13.1-14.4-12.1-9.5-9.0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy